SEC 13F Intelligence

Managers / Q1 2024 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$427M
Q1 2024
Positions
47
Filings on Record
30
2019–present window
Filed
May 1, 2024
original filing

Summary

Sivik Global Healthcare LLC reported $427M in U.S.-listed holdings across 47 positions for Q1 2024.

Its largest position, XBI, represents 6.7% of the portfolio.

Compared with Q4 2023, the fund opened 16 new positions and exited 8.

Portfolio Metrics

Turnover
+17.2%
vs prior filed quarter
Top-10 Concentration
+26.1%
share of reported value
Largest Position
+6.7%
Spdr S P Biotech Etf
New / Exited
16 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 52.0%Other: 36.1%ETP: 6.7%ADR: 5.2%
  • Common Stock · 52.0% · $222M
  • Other · 36.1% · $154M
  • ETP · 6.7% · $28M
  • ADR · 5.2% · $22M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PUT - SPY 100 @ 505 EXP 04/19/2024NEW+3.0K3.0K+$152M$152M
CHRLS RIVER LABSNEW+25.0K25.0K+$7M$7M
EWEDWARDS LIFESCIENCESNEW+70.0K70.0K+$7M$7M
BAXBAXTER INTERNATIONAL INC.NEW+130.0K130.0K+$6M$6M
AVTRAVANTOR INCNEW+213.9K213.9K+$5M$5M
WSTWEST CO INC WDNEW+10.0K10.0K+$4M$4M
BDXBECTON DICKINSON CONEW+15.0K15.0K+$4M$4M
OPCHOPTION CARE HEALTH INCNEW+110.0K110.0K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

46 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH6.67%$28M300.0K
2LLYELI LILLY & COhistory →COM2.92%$12M16.0K
3NVONOVO-NORDISK A/Shistory →ADR2.78%$12M92.5K
4BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM2.17%$9M135.0K
5TMOTHERMO FISHER SCIENTIFIC INC.history →COM2.11%$9M15.5K
6SYKSTRYKER CORPhistory →COM2.10%$9M25.0K
7ISRGINTUITIVE SURGhistory →COM NEW1.87%$8M20.0K
8THCTENET HEALTHCAREhistory →COM NEW1.85%$8M75.0K
9MCKMCKESSON CORPhistory →COM1.82%$8M14.5K
10DHRDANAHER CORPhistory →COM1.76%$7M30.0K
11UHSUNIV HEALTH SVChistory →CLASS B1.71%$7M40.0K
12RMDRESMEDhistory →COM1.64%$7M35.4K
13HUMHUMANA INC.history →COM1.63%$7M20.0K
14CHRLS RIVER LABSCOM1.59%$7M25.0K
15EWEDWARDS LIFESCIENCEShistory →COM1.57%$7M70.0K
16S24SELECT MEDICAL HOLDINGS CORPhistory →COM1.41%$6M200.0K
17INSPINSPIRE MEDICAL SYSTEMS INChistory →COM1.38%$6M27.5K
18HCAHCA HEALTHCARE INChistory →COM1.37%$6M17.5K
19ABTABBOTT LABShistory →COM1.33%$6M50.0K
20SGRYSURGERY PARTNERS INChistory →COM1.33%$6M190.0K
21BAXBAXTER INTERNATIONAL INC.history →COM1.30%$6M130.0K
22ACHCACADIA HEALTHCREhistory →COM1.30%$6M70.0K
23AVTRAVANTOR INChistory →COM1.28%$5M213.9K
24SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.22%$5M205.0K
25PODDINSULET CORPhistory →COM1.21%$5M30.0K
26CAHCARDINAL HEALTHhistory →COM1.18%$5M45.0K
27BMRNBIOMARIN PHARMhistory →COM1.18%$5M57.5K
28EHCENCOMPASS HEALTH CORPhistory →COM1.16%$5M60.0K
29UNHUNITEDHEALTH GRPhistory →COM1.16%$5M10.0K
30DXCMDEXCOMhistory →COM1.14%$5M35.0K
31VRTXVERTEX PHARMACEUTICALS INC.history →COM1.08%$5M11.0K
32WSTWEST CO INC WDCOM0.93%$4M10.0K
33BDXBECTON DICKINSON COCOM0.87%$4M15.0K
34OPCHOPTION CARE HEALTH INCCOM NEW0.86%$4M110.0K
35GEHCGE HEALTHCARE TECHNOLOGYCOMMON STOCK0.85%$4M40.0K
36CICIGNA GROUP/THECOM0.85%$4M10.0K
37NTRANATERA INCCOM0.75%$3M35.0K
38MRVIMARAVAI LIFESCIENCES HLDGS-ACOM CL A0.74%$3M365.0K
39RVTYREVVITY INCCOM0.74%$3M30.0K
40MEDPMEDPACE HOLDINGS INCCOM0.71%$3M7.5K
41CATALENT INCCOM0.66%$3M50.0K
42STEVANATO GROUP SPACOM0.62%$3M83.0K
43TEVATEVA PHARM ADRSPONSORED ADS0.58%$2M175.0K
44BNTXBIONTECH SESPONSORED ADS0.54%$2M25.0K
45BIIBBIOGEN INCCOM0.51%$2M10.0K
46GPCRSTRUCTURE THERAPEUTICS INCSPONSORED ADS0.04%$191,0004.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.